
Global Prothrombin Complex Concentrate(PCC) Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Prothrombin Complex Concentrate(PCC) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Prothrombin Complex Concentrate(PCC) include CSL, WEIGUANG BIOLOGICAL, Taibang Biologic Group, SHANGHAI RAAS, Green Cross, Jiangxi Boya Bio-Pharmaceutical, HUALAN BIOLOGICAL ENGINEERING, Guangdong Shuanglin Biopharmaceutical and Beijing Tiantan Biological Products, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Prothrombin Complex Concentrate(PCC), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Prothrombin Complex Concentrate(PCC), also provides the sales of main regions and countries. Of the upcoming market potential for Prothrombin Complex Concentrate(PCC), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prothrombin Complex Concentrate(PCC) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Prothrombin Complex Concentrate(PCC) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Prothrombin Complex Concentrate(PCC) sales, projected growth trends, production technology, application and end-user industry.
Prothrombin Complex Concentrate(PCC) Segment by Company
CSL
WEIGUANG BIOLOGICAL
Taibang Biologic Group
SHANGHAI RAAS
Green Cross
Jiangxi Boya Bio-Pharmaceutical
HUALAN BIOLOGICAL ENGINEERING
Guangdong Shuanglin Biopharmaceutical
Beijing Tiantan Biological Products
BOHUI
Biotest
Prothrombin Complex Concentrate(PCC) Segment by Type
1000IU
100IU
200IU
300IU
400IU
Prothrombin Complex Concentrate(PCC) Segment by Application
Hopistial
Clinic
Others
Prothrombin Complex Concentrate(PCC) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex Concentrate(PCC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex Concentrate(PCC) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex Concentrate(PCC).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Prothrombin Complex Concentrate(PCC) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prothrombin Complex Concentrate(PCC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prothrombin Complex Concentrate(PCC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Prothrombin Complex Concentrate(PCC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
According to APO Research, The global Prothrombin Complex Concentrate(PCC) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Prothrombin Complex Concentrate(PCC) include CSL, WEIGUANG BIOLOGICAL, Taibang Biologic Group, SHANGHAI RAAS, Green Cross, Jiangxi Boya Bio-Pharmaceutical, HUALAN BIOLOGICAL ENGINEERING, Guangdong Shuanglin Biopharmaceutical and Beijing Tiantan Biological Products, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Prothrombin Complex Concentrate(PCC), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Prothrombin Complex Concentrate(PCC), also provides the sales of main regions and countries. Of the upcoming market potential for Prothrombin Complex Concentrate(PCC), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prothrombin Complex Concentrate(PCC) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Prothrombin Complex Concentrate(PCC) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Prothrombin Complex Concentrate(PCC) sales, projected growth trends, production technology, application and end-user industry.
Prothrombin Complex Concentrate(PCC) Segment by Company
CSL
WEIGUANG BIOLOGICAL
Taibang Biologic Group
SHANGHAI RAAS
Green Cross
Jiangxi Boya Bio-Pharmaceutical
HUALAN BIOLOGICAL ENGINEERING
Guangdong Shuanglin Biopharmaceutical
Beijing Tiantan Biological Products
BOHUI
Biotest
Prothrombin Complex Concentrate(PCC) Segment by Type
1000IU
100IU
200IU
300IU
400IU
Prothrombin Complex Concentrate(PCC) Segment by Application
Hopistial
Clinic
Others
Prothrombin Complex Concentrate(PCC) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex Concentrate(PCC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex Concentrate(PCC) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex Concentrate(PCC).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Prothrombin Complex Concentrate(PCC) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prothrombin Complex Concentrate(PCC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prothrombin Complex Concentrate(PCC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Prothrombin Complex Concentrate(PCC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Table of Contents
193 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Prothrombin Complex Concentrate(PCC) Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Prothrombin Complex Concentrate(PCC) Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Prothrombin Complex Concentrate(PCC) Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Prothrombin Complex Concentrate(PCC) Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Prothrombin Complex Concentrate(PCC) Market Dynamics
- 2.1 Prothrombin Complex Concentrate(PCC) Industry Trends
- 2.2 Prothrombin Complex Concentrate(PCC) Industry Drivers
- 2.3 Prothrombin Complex Concentrate(PCC) Industry Opportunities and Challenges
- 2.4 Prothrombin Complex Concentrate(PCC) Industry Restraints
- 3 Prothrombin Complex Concentrate(PCC) Market by Manufacturers
- 3.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Manufacturers (2020-2025)
- 3.2 Global Prothrombin Complex Concentrate(PCC) Sales by Manufacturers (2020-2025)
- 3.3 Global Prothrombin Complex Concentrate(PCC) Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Prothrombin Complex Concentrate(PCC) Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Prothrombin Complex Concentrate(PCC) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Prothrombin Complex Concentrate(PCC) Manufacturers, Product Type & Application
- 3.7 Global Prothrombin Complex Concentrate(PCC) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Prothrombin Complex Concentrate(PCC) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Prothrombin Complex Concentrate(PCC) Players Market Share by Revenue in 2024
- 3.8.3 2024 Prothrombin Complex Concentrate(PCC) Tier 1, Tier 2, and Tier 3
- 4 Prothrombin Complex Concentrate(PCC) Market by Type
- 4.1 Prothrombin Complex Concentrate(PCC) Type Introduction
- 4.1.1 1000IU
- 4.1.2 100IU
- 4.1.3 200IU
- 4.1.4 300IU
- 4.1.5 400IU
- 4.2 Global Prothrombin Complex Concentrate(PCC) Sales by Type
- 4.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2020-2031)
- 4.2.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2020-2031)
- 4.3 Global Prothrombin Complex Concentrate(PCC) Revenue by Type
- 4.3.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2020-2031)
- 4.3.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2020-2031)
- 5 Prothrombin Complex Concentrate(PCC) Market by Application
- 5.1 Prothrombin Complex Concentrate(PCC) Application Introduction
- 5.1.1 Hopistial
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Prothrombin Complex Concentrate(PCC) Sales by Application
- 5.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2020-2031)
- 5.2.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2020-2031)
- 5.3 Global Prothrombin Complex Concentrate(PCC) Revenue by Application
- 5.3.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2020-2031)
- 5.3.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2020-2031)
- 6 Global Prothrombin Complex Concentrate(PCC) Sales by Region
- 6.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Prothrombin Complex Concentrate(PCC) Sales by Region (2020-2031)
- 6.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region (2020-2025)
- 6.2.2 Global Prothrombin Complex Concentrate(PCC) Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Prothrombin Complex Concentrate(PCC) Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Prothrombin Complex Concentrate(PCC) Revenue by Region
- 7.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Region
- 7.1.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2020-2025)
- 7.1.3 Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2026-2031)
- 7.1.4 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Prothrombin Complex Concentrate(PCC) Revenue (2020-2031)
- 7.2.2 North America Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Prothrombin Complex Concentrate(PCC) Revenue (2020-2031)
- 7.3.2 Europe Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Prothrombin Complex Concentrate(PCC) Revenue (2020-2031)
- 7.4.2 Asia-Pacific Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 CSL
- 8.1.1 CSL Comapny Information
- 8.1.2 CSL Business Overview
- 8.1.3 CSL Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 CSL Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.1.5 CSL Recent Developments
- 8.2 WEIGUANG BIOLOGICAL
- 8.2.1 WEIGUANG BIOLOGICAL Comapny Information
- 8.2.2 WEIGUANG BIOLOGICAL Business Overview
- 8.2.3 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.2.5 WEIGUANG BIOLOGICAL Recent Developments
- 8.3 Taibang Biologic Group
- 8.3.1 Taibang Biologic Group Comapny Information
- 8.3.2 Taibang Biologic Group Business Overview
- 8.3.3 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.3.5 Taibang Biologic Group Recent Developments
- 8.4 SHANGHAI RAAS
- 8.4.1 SHANGHAI RAAS Comapny Information
- 8.4.2 SHANGHAI RAAS Business Overview
- 8.4.3 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.4.5 SHANGHAI RAAS Recent Developments
- 8.5 Green Cross
- 8.5.1 Green Cross Comapny Information
- 8.5.2 Green Cross Business Overview
- 8.5.3 Green Cross Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 Green Cross Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.5.5 Green Cross Recent Developments
- 8.6 Jiangxi Boya Bio-Pharmaceutical
- 8.6.1 Jiangxi Boya Bio-Pharmaceutical Comapny Information
- 8.6.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
- 8.6.3 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.6.4 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.6.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
- 8.7 HUALAN BIOLOGICAL ENGINEERING
- 8.7.1 HUALAN BIOLOGICAL ENGINEERING Comapny Information
- 8.7.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
- 8.7.3 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.7.4 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.7.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
- 8.8 Guangdong Shuanglin Biopharmaceutical
- 8.8.1 Guangdong Shuanglin Biopharmaceutical Comapny Information
- 8.8.2 Guangdong Shuanglin Biopharmaceutical Business Overview
- 8.8.3 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.8.4 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.8.5 Guangdong Shuanglin Biopharmaceutical Recent Developments
- 8.9 Beijing Tiantan Biological Products
- 8.9.1 Beijing Tiantan Biological Products Comapny Information
- 8.9.2 Beijing Tiantan Biological Products Business Overview
- 8.9.3 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.9.4 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.9.5 Beijing Tiantan Biological Products Recent Developments
- 8.10 BOHUI
- 8.10.1 BOHUI Comapny Information
- 8.10.2 BOHUI Business Overview
- 8.10.3 BOHUI Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.10.4 BOHUI Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.10.5 BOHUI Recent Developments
- 8.11 Biotest
- 8.11.1 Biotest Comapny Information
- 8.11.2 Biotest Business Overview
- 8.11.3 Biotest Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.11.4 Biotest Prothrombin Complex Concentrate(PCC) Product Portfolio
- 8.11.5 Biotest Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Prothrombin Complex Concentrate(PCC) Value Chain Analysis
- 9.1.1 Prothrombin Complex Concentrate(PCC) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Prothrombin Complex Concentrate(PCC) Production Mode & Process
- 9.2 Prothrombin Complex Concentrate(PCC) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Prothrombin Complex Concentrate(PCC) Distributors
- 9.2.3 Prothrombin Complex Concentrate(PCC) Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.